BIOCHEMICAL MECHANISM OF AMYLOID DISEASE
BIOCHEMICAL MECHANISM OF AMYLOID DISEASE
批准号:
2145516
负责人:
JEFFERY W KELLY
金额:
$9.87万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1998-04-30
关键词:
SDS polyacrylamide gel electrophoresis acidity /alkalinity amyloid proteins amyloidosis calcium chemical kinetics conformation crosslink electron microscopy gene mutation hereditary peripheral nervous system disorder high performance liquid chromatography light scattering lysosomes mass spectrometry mutant nuclear magnetic resonance spectroscopy polymerase chain reaction polymerization protein denaturation protein folding protein reconstitution protein sequence protein structure proteolysis retinoid binding proteins thyroid hormone binding protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long term goal of this research is to understand the biochemical
mechanism of amyloid disease. Amyloid fibril formation refers to the
abnormal self-assembly of a normally soluble protein into an insoluble
cross beta-sheet quaternary structural form and is the causative agent in
amyloid disease. Understanding how a normally soluble protein is
transformed into amyloid fibrils is a critical part of understanding the
mechanism of this disease and is the focus of this proposal. The protein
transthyretin composes the amyloid fibrils in two different types of
human amyloid disease. The mechanism of transthyretin amyloid fibril
formation will be studied using an in vitro system that simulates the low
pH environment of the organelle where amyloid fibril formation is thought
to occur in vivo. The advantage of this in vitro system is its
simplicity, which will enable us to make careful measurements.
The acid-mediated partial denaturation of transthyretin is sufficient for
amyloid fibril formation in vitro. A structured acidic-form of
transthyretin appears to be the precursor that assembles into amyloid
fibrils. Transthyretin denaturation and amyloid fibril formation are
competitive processes that can now be studied individually due to the
discovery of an inhibitor which prevents amyloid fibril formation without
noticeably interfering with the denaturation pathway. Thus, in the
presence of amyloid inhibitor, transthyretin denaturation can be studied
and in the absence of inhibitor, fibril formation can be studied. It is
our priority to identify the nature of the transthyretin denaturation
intermediate competent to form fibrils. The denaturation pathway and the
ability of transthyretin variants to form fibrils will also be examined
in the course of these studies. Structurally based amyloid inhibitors
will be tested with regard to their ability to curb amyloid fibril
formation. Successful inhibitors in combination with kinetic and
thermodynamic denaturation and fibril formation studies should allow a
mechanism of fibril formation to be formulated.
Long term structural studies on certain acid induced conformations of
transthyretin will be initiated during these studies with the ultimate
goal of characterizing the denaturation intermediate that is the
precursor to amyloid fibrils.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Probing the Proteinopathy Component of Light Chain Amyloidosis Pharmacologically
-
批准号:10440457
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2021
-
负责人:JEFFERY W KELLY
-
依托单位:
Probing the Proteinopathy Component of Light Chain Amyloidosis Pharmacologically
-
批准号:10186362
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2021
-
负责人:JEFFERY W KELLY
-
依托单位:
Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias
-
批准号:10281046
-
项目类别:
-
资助金额:$260.17万
-
财政年份:2021
-
负责人:JEFFERY W KELLY
-
依托单位:
Probing the Proteinopathy Component of Light Chain Amyloidosis Pharmacologically
-
批准号:10625486
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2021
-
负责人:JEFFERY W KELLY
-
依托单位:
Proteostasis Regulator Pharmacology Core D
-
批准号:10183113
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2018
-
负责人:JEFFERY W KELLY
-
依托单位:
Proteostasis Regulator Pharmacology Core D
-
批准号:10432030
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2018
-
负责人:JEFFERY W KELLY
-
依托单位:
Interplay of Intrinsic and Extrinsic Effects of N-glycans on Glycoproteostasis
-
批准号:9520024
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2015
-
负责人:JEFFERY W KELLY
-
依托单位:
Interplay of Intrinsic and Extrinsic Effects of N-glycans on Glycoproteostasis
-
批准号:8946941
-
项目类别:
-
资助金额:$43.14万
-
财政年份:2015
-
负责人:JEFFERY W KELLY
-
依托单位:
Interplay of Intrinsic and Extrinsic Effects of N-glycans on Glycoproteostasis
-
批准号:9116133
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2015
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering Small Molecule Activators of Stress-responsive Signaling
-
批准号:9904304
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering Small Molecule Activators of Stress-responsive Signaling
-
批准号:10383671
-
项目类别:
-
资助金额:$60.17万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering small molecules activators of stress responsive signaling
-
批准号:8624805
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering small molecules activators of stress responsive signaling
-
批准号:8638879
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering small molecules activators of stress responsive signaling
-
批准号:8828534
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering small molecules activators of stress responsive signaling
-
批准号:9050601
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Discovering Small Molecule Activators of Stress-Responsive Signaling
-
批准号:10599752
-
项目类别:
-
资助金额:$262.11万
-
财政年份:2013
-
负责人:JEFFERY W KELLY
-
依托单位:
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
-
批准号:8020112
-
项目类别:
-
资助金额:$195.65万
-
财政年份:2009
-
负责人:JEFFERY W KELLY
-
依托单位:
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
-
批准号:8215836
-
项目类别:
-
资助金额:$195.65万
-
财政年份:2009
-
负责人:JEFFERY W KELLY
-
依托单位:
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
-
批准号:7563376
-
项目类别:
-
资助金额:$225.11万
-
财政年份:2009
-
负责人:JEFFERY W KELLY
-
依托单位:
Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration
-
批准号:8429423
-
项目类别:
-
资助金额:$184.89万
-
财政年份:2009
-
负责人:JEFFERY W KELLY
-
依托单位: